Cocoon Medical (“Cocoon”), a leading global developer and provider of energy-based aesthetic systems for practitioners based in Barcelona, Spain, is pleased to announce the US introduction of its Primelase™ diode laser platform.
| TUSTIN, Calif., March 10, 2020 /PRNewswire/ -- Cocoon Medical (“Cocoon”), a leading global developer and provider of energy-based aesthetic systems for practitioners based in Barcelona, Spain, is pleased to announce the US introduction of its Primelase™ diode laser platform.
Introduced in 2014, Primelase is the first and only diode laser that guarantees a 4.800W maximum power, providing peak performance and highest profitability on the market. Primelase offers four different wavelengths including a combination of three wavelengths at once for safe and effective hair removal on all skin types, including tanned skin. Due to its high power, speed and ultra short pulse duration, it enables providers to offer a very effective hair removal that is safe for all skin types and all types of hair, including residual hair. The system provides an efficient treatment experience that, combined with an unparalleled long applicator life and extremely low running costs, ensures high profitability for providers. In fact, a woman’s both legs can be treated in as little as 12 minutes, and a man’s back takes only four minutes. “We are pleased to bring our Primelase technology to the U.S. market to usher Cocoon Medical into our next phase of growth and global expansion. At present, there are 2,500 systems in operation around the world, and our signature platform Primelase is our first introduction to the vast U.S. market. Cocoon maintains a healthy product pipeline, so we are well positioned to expand our footprint internationally by delivering superior products to our physician partners in the categories of laser hair removal and body shaping,” says Miguel Pardos, Chief Executive Officer. According to Dermatologist and Owner of Gold Skin Care Center in Nashville, TN, Michael Gold, MD, “The Primelase device offers several advantages to aesthetic practitioners, most notably, the speed at which you can treat hair on all skin types and the ability to treat residual hair that other technologies cannot achieve.” For more information about Primelase, contact Sergio Blumenblat, Vice President North America, sblumenblat@cocoonmedical.com or 510-612-5461. About Cocoon Medical Founded in 2010 by José Antonio Sánchez, Chairman and Founder of Cocoon Group, Cocoon Medical is a privately-owned international corporation headquartered in Barcelona, Spain. The company’s mission is to offer the most advanced technology and innovation to the field of aesthetic medicine, developing medical and aesthetic equipment to meet and exceed the needs of the most demanding customers. Cocoon continues to expand internationally with distribution currently in 80 countries through a network of over 25 distributors as well as a direct sales force. Additionally, the company owns and operates a successful group of over 250 Centros Unico hair removal and aesthetic medical clinics throughout Spain. Cocoon Medical prides itself on a continuous investment in its R & D department and factories to develop industry leading innovations combined with the highest national and international certifications for quality and service in the aesthetics market worldwide. For more information, http://www.cocoonmedical.com
SOURCE Cocoon Medical |
View original content to download multimedia:
